(Q34724301)

4 August 2017

Coeliac disease in the year 2000: exploring the iceberg (English)

1 reference

4 August 2017

1 reference

C Catassi

1

1 reference

4 August 2017

I M Rätsch

2

1 reference

4 August 2017

E Fabiani

3

1 reference

4 August 2017

M Rossini

4

1 reference

4 August 2017

F Bordicchia

5

1 reference

4 August 2017

F Candela

6

1 reference

4 August 2017

G V Coppa

7

1 reference

4 August 2017

P L Giorgi

8

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 January 1994

1 reference

4 August 2017

1 reference

4 August 2017

343

1 reference

4 August 2017

8891

1 reference

4 August 2017

200-203

1 reference

Coeliac disease and malignancy

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990989-X

7 January 2021

Mortality in celiac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990989-X

7 January 2021

Malignancy in coeliac disease--effect of a gluten free diet

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990989-X

7 January 2021

Anti-gliadin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990989-X

7 January 2021

Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990989-X

7 January 2021

IgA antigliadin antibodies: a marker of mucosal damage in childhood coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990989-X

7 January 2021

Coeliac disease associated with recurrent aphthae

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990989-X

7 January 2021

Antigliadin and antiendomysium antibody determination for coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990989-X

7 January 2021

Endomysial antibody: is it the best screening test for coeliac disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990989-X

7 January 2021

Can antigliadin antibody detect symptomless coeliac disease in children with short stature?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990989-X

7 January 2021

Screening of diabetic children for coeliac disease with antigliadin antibodies and HLA typing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990989-X

7 January 2021

Gliadin immune reactivity is associated with overt and latent enteropathy in relatives of celiac patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990989-X

7 January 2021

IgG, IgA and IgE gliadin antibody determinations as screening test for untreated coeliac disease in children, a multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990989-X

7 January 2021

Selective IgA deficiency in blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990989-X

7 January 2021

Selective IgA deficiency and coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2990989-X

7 January 2021

10.1016/S0140-6736(94)90989-X

Identifiers

DOI

1 reference

4 August 2017

1 reference